Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

VCT220

VICTOR-HTN

Vincentage Pharma Co · Phase 2 · Active, not recruiting · Enrollment 160

NCT07360275

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
VCT220 80mgn/rn/rn/rn/r
Placebon/rn/rn/rn/r
VCT220 160mg (1)n/rn/rn/rn/r
VCT220 160mg (2)n/rn/rn/rn/r

Not shown

  • VCT220 80mg: endpoint not reported
  • Placebo: endpoint not reported
  • VCT220 160mg (1): endpoint not reported
  • VCT220 160mg (2): endpoint not reported